ESMO Plenary 2021
Update of ESMO MBC 2021 Guideline with focus on clinical evidence
EMSO MBC Guideline 2021
ESMO Plenary 2021
Update of ESMO MBC 2021 Guideline with focus on…
EMSO MBC Guideline 2021
ESMO Plenary 2021
TNBC: what is important? Marker first!
EMSO MBC Guideline 2021
ESMO Plenary 2021
Luminal MBC: what is important?
EMSO MBC Guideline 2021
ESMO Plenary 2021
HER2+: what is important? New drugs!
EMSO MBC Guideline 2021
ESMO Plenary 2021
Carcinoma mammario metastatico - cosa è importante?
EMSO MBC Guideline 2021
ESMO Plenary 2021
Update der ESMO Leitlinie 2021 zum metastasierten…
monarchE
ESMO Plenary 2021 MonarchE
monarchE with 27 months of FU: Practice changing -…
monarchE
ESMO Plenary 2021 monarchE
monarchE Update: Strong effect of Abemaciclib confirmed…
monarchE
ESMO Plenary 2021 MonarchE
monarchE Update: Clinically significant and meaningful…
monarchE
ESMO Plenary 2021 monarchE
monarchE Update: Starker Effekt der Abemaciclib…
ESMO Plenary 2021
KEYNOTE-522: What's new?
ESMO Plenary 2021
IMpassion031 vs. KEYNOTE-522: similar pCR, no biomarker…
ESMO Plenary 2021
CPI patient selection: CPS vs. response
ESMO Plenary 2021
What about BRCA+ TNBC? PARPi or CPI? PARPi + CPI?
ESMO Plenary 2021
Will CPI change breast cancer treatment on a global…
ESMO Plenary 2021
CPI duration? non-pCR TNBC? Global access to therapies?…
ESMO Plenary 2021
KEYNOTE-522: First CPI in TNBC with pCR and EFS…
ESMO Plenary 2021
KEYNOTE-522 - a practice changer!
ESMO Plenary 2021
KEYNOTE-522: What is new?
ESMO Plenary 2021
KEYNOTE-522: Cosa è veramente importante?
ESMO Plenary 2021
KEYNOTE-522 - praxis verändernd!
ESMO Plenary 2021
KEYNOTE-522: Que novedades hay?
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!